Aprin Pharmed



HYNIC-TOC is a peptide radiopharmaceutical consisting of two parts, an octreotide-like peptide chain and a chelating agent called HYNIC that binds to somatostatin receptors on the surface of cancer tumors. Additionally, it is used in the diagnosis and monitoring of neuroendocrine malignancies, most of which are found in the bowel, pancreas, or lungs.


CAS registration number
  • 257943-19-4
molecular mass
  • 1284.38 گرم بر مول
Molecular formula
  • C55H71N13O12S2.C2HF3O2
  • white powder
  • HYNIC-[Tyr3] Octreotide
Peptide sequence
  • Hynic-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OL (Disulfide Bridge Cys2-Cys7)
  • 2-8 degrees Celsius
Therapeutic applications
  • Positron Emission Tomography (PET) imaging or radionuclide therapy